[18F]FMISO PET/CT imaging of hypoxia as a non-invasive biomarker of disease progression and therapy efficacy in a preclinical model of pulmonary fibrosis: comparison with the [18F]FDG PET/CT approach

Lung CT Densitometry in Idiopathic Pulmonary Fibrosis for the Prediction of Natural Course, Severity, and Mortality

(2019) Benjamin Loeh et al.   CHEST

High-Resolution Computed Tomography (HRCT) Reflects Disease Progression in Patients with Idiopathic Pulmonary Fibrosis (IPF): Relationship with Lung Pathology

(2019) Elisabetta Cocconcelli et al.   Journal of Clinical Medicine

Prediction of idiopathic pulmonary fibrosis progression using early quantitative changes on CT imaging for a short term of clinical 18–24-month follow-ups

(2019) Grace Hyun J. Kim et al.   EUROPEAN RADIOLOGY

High-Resolution CT Change over Time in Patients with Idiopathic Pulmonary Fibrosis on Antifibrotic Treatment

(2019) Elisabetta Balestro et al.   Journal of Clinical Medicine

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice

(2018) Francesca Ruscitti et al.   Jove-Journal of Visualized Experiments

HIF-1α triggers ER stress and CHOP-mediated apoptosis in alveolar epithelial cells, a key event in pulmonary fibrosis

(2018) Eva Delbrel et al.   Scientific Reports

Cherenkov luminescence imaging is a fast and relevant preclinical tool to assess tumour hypoxia in vivo

(2018) Emiko Desvaux et al.   EJNMMI Research

Longitudinal assessment of bleomycin-induced lung fibrosis by Micro-CT correlates with histological evaluation in mice

(2017) Francesca Ruscitti et al.   MULTIDISCIPLINARY RESPIRATORY MEDICINE

Idiopathic pulmonary fibrosis

(2017) Fernando J. Martinez et al.   Nature Reviews Disease Primers

18 F-fluoromisonidazole PET and Activity of Neoadjuvant Nintedanib in Early HER2-Negative Breast Cancer: A Window-of-Opportunity Randomized Trial

(2016) Miguel Quintela-Fandino et al.   CLINICAL CANCER RESEARCH

Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis

(2015) Na Xie et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Longitudinal micro-CT provides biomarkers of lung disease that can be used to assess the effect of therapy in preclinical mouse models, and reveal compensatory changes in lung volume

(2015) Greetje Vande Velde et al.   Disease Models & Mechanisms

Monitoring vascular normalization induced by antiangiogenic treatment with 18F-fluoromisonidazole-PET

(2015) Elena Hernández-Agudo et al.   Molecular Oncology

miR-210 promotes IPF fibroblast proliferation in response to hypoxia

(2014) Vidya Bodempudi et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

18F-Fluoromisonidazole PET Uptake Is Correlated with Hypoxia-Inducible Factor-1  Expression in Oral Squamous Cell Carcinoma

(2013) J. Sato et al.   JOURNAL OF NUCLEAR MEDICINE

The current position of surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis

(2013) Riitta Kaarteenaho   RESPIRATORY RESEARCH

Lactic Acid Is Elevated in Idiopathic Pulmonary Fibrosis and Induces Myofibroblast Differentiation via pH-Dependent Activation of Transforming Growth Factor-β

(2012) Robert Matthew Kottmann et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Delayed Access and Survival in Idiopathic Pulmonary Fibrosis

(2011) Daniela J. Lamas et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Hypoxia Inducible Factor 1α Signaling in Fractionated Radiation-Induced Lung Injury: Role of Oxidative Stress and Tissue Hypoxia

(2010) Z. N. Rabbani et al.   RADIATION RESEARCH

Idiopathic Pulmonary Fibrosis and Diffuse Parenchymal Lung Disease: Implications from Initial Experience with 18F-FDG PET/CT

(2009) A. M. Groves et al.   JOURNAL OF NUCLEAR MEDICINE

Comparison between conventional and "clinical" assessment of experimental lung fibrosis

(2008) Kjetil Ask et al.   Journal of Translational Medicine